Literature DB >> 2466456

Bsp 12861 restriction fragment length polymorphism detects Ag(c/g) locus of human apolipoprotein B in all 17 persons studied.

Y H Ma1, X B Wang, R Bütler, V N Schumaker.   

Abstract

Southern blot analysis of the genomic DNA from 17 individuals showed perfect correspondence between a Bsp 12861 restriction fragment length polymorphism (RFLP) and the Ag(c/g) locus on human apolipoprotein (apo) B. The RFLP polymorphism is caused by a C--------T transition at nucleotide 421 on the cDNA, resulting in a threonine-to-isoleucine conversion. Thus, three of the five Ag sites have now been tentatively located on the 4536 residue apo B peptide at amino acyl residues 71: Ag(c/g), 591 (Ag(a1/d), and 4154 Ag(t/z).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2466456     DOI: 10.1161/01.atv.9.2.242

Source DB:  PubMed          Journal:  Arteriosclerosis        ISSN: 0276-5047


  4 in total

1.  Two amino acid substitutions in apolipoprotein B are in complete allelic association with the antigen group (x/y) polymorphism: evidence for little recombination in the 3' end of the human gene.

Authors:  A M Dunning; H H Renges; C F Xu; R Peacock; R Brasseur; G Laxer; M J Tikkanen; R Bütler; N Saha; A Hamsten
Journal:  Am J Hum Genet       Date:  1992-01       Impact factor: 11.025

Review 2.  The apolipoprotein multigene family: structure, expression, evolution, and molecular genetics.

Authors:  L Chan
Journal:  Klin Wochenschr       Date:  1989-02-15

3.  Familial ligand-defective apolipoprotein B. Identification of a new mutation that decreases LDL receptor binding affinity.

Authors:  C R Pullinger; L K Hennessy; J E Chatterton; W Liu; J A Love; C M Mendel; P H Frost; M J Malloy; V N Schumaker; J P Kane
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

4.  Identification of the ancestral haplotype for apolipoprotein B suggests an African origin of Homo sapiens sapiens and traces their subsequent migration to Europe and the Pacific.

Authors:  J Rapacz; L Chen; E Butler-Brunner; M J Wu; J O Hasler-Rapacz; R Butler; V N Schumaker
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.